Disitamab vedotin

我们是谁

  • 12 月 8, 2022
    Pembrolizumab and Disitamab Vedotin in HER2-expressing Metastatic Colorectal Cancer
  • 12 月 8, 2022
    Disitamab Vedotin Combined With Tislelizumab in Advanced HER2 Positive Colorectal Cancer